SCHEMBL7075810

SCHEMBL7075810

O=C(O)N1C(=O)O[C@@H](CO)[C@@H]1c1ccc(F)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 5/20 0.40
ADRA1B P35368 4/20 0.40
ADRA1D P25100 3/20 0.40
HRH1 P35367 1/20 0.40
KDM1A O60341 2/20 0.32
HTR7 P34969 1/20 0.32
TSHR P16473 1/20 0.32
USP5 P45974 2/20 0.31
HDAC6 Q9UBN7 1/20 0.31
SLC5A2 P31639 1/20 0.31
EDNRB P24530 1/20 0.31
HCAR3 P49019 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
ABCB1 P08183 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30
CES2 O00748 1/20 0.30
CES1 P23141 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7083169 1.00 ADRA1A (0.40) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL7083166 1.00 ADRA1A (0.40) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL6082094 0.82 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL6959819 0.82 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL7095750 0.82 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL7874288 0.81 CYP19A1 (0.37) ADRA1AADRA1BADRA1DHRH1TSHR
SCHEMBL8186925 0.80 HTR2B (0.34) ADRA1AADRA1BADRA1DHRH1
SCHEMBL6961064 0.79 ADRA1A (0.41) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL6961998 0.79 ADRA1A (0.41) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL7976303 0.78 ADRA1A (0.38) ADRA1AADRA1BADRA1DHRH1USP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP claimed
US-6228870-B1 BENIGN PROSTATIC HYPERPLASIA; REDUCTION OF HYPOTENSION SIDE EFFECT MERCK & CO., INC. 2001-05-08 US claimed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP claimed
US-6037354-A ADMINISTERING PHENYL-SUBSTITUTED THIAZOLIDIN-4-ONE OR OXAZOLIDIN-2-ONE DERIVATIVE TO TREAT BENIGN PROSTATE HYPERPLASIA; SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 2000-03-14 US claimed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO claimed
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP disclosed
US-6255315-B1 BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-07-03 US disclosed
US-6228870-B1 BENIGN PROSTATIC HYPERPLASIA; REDUCTION OF HYPOTENSION SIDE EFFECT MERCK & CO., INC. 2001-05-08 US disclosed
US-6143750-A NITROGEN HETEROCYCLIC COMPOUNDS AS ENZYME INHIBITORS, FOR PROSTATE PROBLEMS AND MUSCLE RELAXANTS MERCK & CO., INC. (US) 2000-11-07 US disclosed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP disclosed
US-6037354-A ADMINISTERING PHENYL-SUBSTITUTED THIAZOLIDIN-4-ONE OR OXAZOLIDIN-2-ONE DERIVATIVE TO TREAT BENIGN PROSTATE HYPERPLASIA; SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 2000-03-14 US disclosed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed